Total Funding
74
38
Total FundingGrant raised
Growth Score
-6 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
35433
Eascra Biotech develops DNA nanostructures to create stable nanomaterials for biomedical applications.
- Yupeng Chen: Co-Founder and Science Advisor
- Mari Snow: CEO and Co-FounderPast Role: Remote Nation, CEO and Founder
About the Company
Eascra Biotech creates Janus base nanomaterials based on DNA nanotechnology that are highly effective and super biocompatible for articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions. Its three generations of DNA-inspired nanotubes are a low-cost, scalable alternative to existing options. Its Janus
nanotechnologies can be tailored to improve the therapeutic efficacy of drug treatments for a variety of chronic conditions and medical needs.
